ADCC-Enhanced anti-ABCA1 (clone 3/84) is a non-fucosylated therapeutic biobetter antibody engineered by Creative Biolabs' Afuco™ technology platform. By reducing the fucosylation of the Fc region, the ADCC-enhanced antibody shows an increased binding affinity for the FcyR receptor on immune effector cells. ADCC-Enhanced anti-ABCA1 biobetter https://adcc.creative-biolabs.com/adcc-enhanced-anti-abca1-biobetter-1011.htm